Regulatory Lipogems Announces Enrollment of the Final Patient in ARISE FDA Clinical Trials for Knee Osteoarthritis byJosh SandbergMarch 5, 2025
Sports Medicine Sparta Biomedical Reports Treatment of First Patients with Breakthrough Device, Ormi byTim AllenSeptember 17, 2024
Recon HSS Launches Clinical Trial to Address Post-Traumatic Osteoarthritis after ACL Revision Surgery byTim AllenMay 20, 2024
Recon Sports Medicine Top Stories New Study from HSS Reveals Minimally Invasive Procedure Can Delay Arthritis in Select Patients with Hip Impingement byJosh SandbergApril 18, 2024
Recon Orthopedic Surgeon Tomas Pevny, MD, of Valley View, Is the First in the Roaring Fork Valley to Offer iovera°, a New Option to Manage Knee Pain byJosh SandbergFebruary 13, 2024
Recon AAOS Updates Clinical Practice Guideline for the Management of Osteoarthritis of the Hip byJosh SandbergJanuary 23, 2024
Biologics Regulatory Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis byJosh SandbergDecember 7, 2023
Recon Regulatory ZKR Orthopedics announces FDA Breakthrough Device designation for the LIFT Implant Technology byJosh SandbergOctober 10, 2023
Biologics Regulatory U.S. FDA Grants Lipogems® Second IDE Approval For A Clinical Trial On The Treatment For Knee OA byJosh SandbergOctober 4, 2023
